United States Senators, Dianne Feinstein and Susan Collins have introduced the ‘Prevention of Antibiotic Resistance Act of 2015’ that will require the withdrawal of approval of some medically important antibiotics for use in animals.
If approved the bill would require the Food and Drug Administration (FDA) to withdraw its approval of medically-important antibiotics used for disease prevention or control that are at high risk of abuse, unless the producer of the drug can demonstrate that its use in agriculture does not pose a risk to human health. Antibiotics that meet the standard for prevention and control uses would be issued a revised label that supports prudent antibiotic use.
The bill addresses a gap in the guidelines issued by FDA in December 2013, which called on the industry to eliminate the use of antibiotics for the purpose of making animals gain weight.
FDA estimates that 107 antibiotics used for therapeutic purposes, including disease prevention or control, do not have a defined duration of therapy or are labeled for continuous use. An analysis by the Pew Charitable Trusts estimates that 83 antibiotics used for disease prevention or control have an overlapping dose with a production use. These antibiotics are at high risk of being inappropriately administered, which could pose a risk to human health.
The Prevention of Antibiotic Resistance Act is endorsed by the American Public Health Association, the Infectious Disease Society of America, Trust for America’s Health, the American College of Preventive Medicine and the Pew Charitable Trusts.
It is cosponsored by Senators Kirsten Gillibrand (D-N.Y.) and Elizabeth Warren (D-Mass.).
"*" indicates required fields
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (23) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.